Related Experiment Video
Updated: May 20, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Two cases of giant cell hepatitis in HIV-infected patients
L Falasca1, F Del Nonno, F Palmieri
1Laboratory of Electron Microscopy, INMI-IRCCS ‘L Spallanzani’, Rome, Italy. falasca@inmi.i
Insights
Giant cell hepatitis (GCH) is rare in adult HIV patients. In this study, GCH did not affect the clinical course of hepatitis in HIV/HCV co-infected patients receiving therapy.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Giant cell hepatitis (GCH) is an uncommon liver condition.
- Its occurrence and impact in adult patients with human immunodeficiency virus (HIV) are not well-documented.
- Hepatitis C virus (HCV) co-infection is frequent in HIV patients.
Observation:
- Two adult cases of GCH were identified among 81 patients with HIV co-infected with HCV.
- Both patients were undergoing highly active antiretroviral therapy (HAART).
Findings:
- Both patients achieved sustained virological response to HCV.
- Both patients experienced suppression of HCV viral load.
- Both patients achieved HIV viral suppression with HAART.
- The presence of giant cells in the liver did not appear to alter the clinical progression of hepatitis.
Implications:
- Giant cell hepatitis may not negatively impact the clinical course of hepatitis in HIV/HCV co-infected individuals.
- Further research is needed to understand the role of GCH in this patient population.
- Effective management of HIV and HCV co-infection may mitigate potential complications associated with GCH.
Abstract:
Giant cell hepatitis (GCH) has been rarely described in adult HIV patients, and its outcome remain unknown. We report two cases of GCH among 81 HIV patients co-infected with the hepatitis C virus (HCV). Both patients had a sustained virological response, suppression of HCV viral load and HIV viral suppression after highly active antiretroviral therapy. Our findings would suggest that the presence of giant cells does not influence the clinical course of hepatitis.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

